Scoping review reveals broad chemical diversity but sparse regional toxicity data for nine medicinal plant species, indicating an urgent need for conservation-aware safety research.
The Turkistan Region of southern Kazakhstan lies within the Mountains of Central Asia biodiversity hotspot and harbors a flora of beneficial plants whose traditional use is well documented but whose chemistry and conservation status remain, for most species, formally unassessed. Following the PRISMA extension for Scoping Reviews (PRISMA-ScR), with accepted names verified against Plants of the World Online, this scoping review maps—for the first time as a single co-occurring assemblage rather than isolated single-taxon surveys—the evidence for nine regionally important species across the Nitrariaceae, Fabaceae, Apiaceae and Asteraceae. From 4362 records, 82 were charted by structured per-species extraction. The species span a broad chemical space: β-carboline alkaloids, furanocoumarins, sesquiterpene coumarins, sesquiterpene lactones and flavonoid-rich essential oils, sharing a recurring antioxidant and antimicrobial profile overlaid with species-specific effects such as the anthelmintic santonin of Artemisia cina. For most species the underlying data derive from non-Central Asian populations, limiting regional transferability, and safety evidence is sparse: no acute or repeated-dose toxicity study on regionally collected material was identified, although several species contain monoamine oxidase inhibitors, phototoxic furanocoumarins or thujone-rich oils. We propose a tiered, conservation-aware framework and a prioritized research agenda. Provenance was charted for all 82 records, and the country of origin could be established for 35.
No takes yet. Share an insight, caveat, or question.
Karzhaubay et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: